Previous 10 | Next 10 |
- Enrollment completed in older adults portion of Phase 1/1b trial of IVX-121, a virus like particle (VLP) vaccine candidate displaying the prefusion stabilized Respiratory Syncytial Virus (RSV) F antigen - - Topline, interim Phase 1/1b data for IVX-121 in RSV, including younger...
Gainers: Sabre Corporation (SABR) +11%. Kura Sushi USA (KRUS) +11%. WD-40 Company (WDFC) +10%. MediWound (MDWD) +7%. Cognyte Software (CGNT) +5%. Losers: OraSure Technologies (OSUR) -5%. Momentus (MNTS) -5%. Icosavax (ICVX) -5%. Berkeley ...
Icosavax (NASDAQ:ICVX) shares rose 6% in early Wednesday trading after the director Mark Mcdade bought 42,225 shares at $7.10 each, worth $300K. The transaction takes Mcdade's direct beneficial ownership to 50,243 shares. Quick look through company's ownership structure: Earlier (Ma...
Gainers: Tilray Brands (TLRY) +15%. Clever Leaves (CLVR) +12%. Ensysce Biosciences (ENSC) +11%. Icosavax (ICVX) +10%. Cullinan Oncology (CGEM) +6%. Losers: Celsion (CLSN) -19%. IMARA (IMRA) -14%. Owlet (OWLT) -12%. PAVmed (PAVM) -10%. Accelerate Diagnos...
The shares of Icosavax (ICVX +28.5%) have recorded the biggest ever intraday gain after the development-stage biotech reported its 4Q financials for 2021, which exceeded Street forecasts on revenue. The growth for the period stood at ~28% YoY thanks to ~$2.1M of grant revenue, up from $1...
Gainers: Longeveron (LGVN) +62%. Clovis Oncology (CLVS) +61%. Icosavax (ICVX) +26%. Integrated Media Technology (IMTE) +28%. SAB Biotherapeutics (SABS) +21%. Local Bounti (LOCL) +21%. CPS Technologies (CPSH) +18%. Vector Group (VGR) +17%. Nano-X Imaging (NNOX) +16%. Vertex Energy (VTNR) +16%....
Shares of Icosavax (NASDAQ: ICVX) were soaring 28.3% as of 11:22 a.m. ET on Thursday. The big gain came after the biopharmaceutical company provided its fourth-quarter update following the market close on Wednesday. Investors weren't focused very much on Icosavax's Q4 financial ...
Gainers: Clovis Oncology CLVS +68%. Longeveron LGVN +36%. Icosavax (ICVX) +27%. Creative Medical Technology (CELZ) +25%. Nano-X Imaging NNOX +22%. Losers: Clarus Therapeutics CRXT -27%. Acutus Medical AFIB -18%. Vyant Bio VYNT -15%. Phree...
Icosavax press release (NASDAQ:ICVX): Q4 GAAP EPS of -$0.46 misses by $0.03. Revenue of $2.07M (+27.8% Y/Y) beats by $0.97M. For further details see: Icosavax GAAP EPS of -$0.46 misses by $0.03, revenue of $2.07M beats by $0.97M
- Completed dosing in older adults portion of Phase 1/1b clinical trial for IVX-121, a VLP vaccine candidate displaying the prefusion stabilized Respiratory Syncytial Virus (RSV) F antigen - - Company anticipates topline, interim data for RSV lead program IVX-121 in 2Q 2022 - ...
News, Short Squeeze, Breakout and More Instantly...
Shandong Weigao Group Medical Polymer Co. Ltd. - Class H (SHWGF) is expected to report for Q4 2023 Country Garden Holdings Co., Ltd. ADR (CTRYY) is expected to report for Q4 2023 Mondi Plc ADR (New) (MONDY) is expected to report for Q4 2023 Telecom Italia S.p.A. ADR - Preference Share...
NEW YORK, NY / ACCESSWIRE / February 1, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: AVROBIO, Inc. (NASDAQ:AVRO)'s merge...
2024-01-09 00:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...